(LGND) Ligand Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Ligand Pharmaceuticals | (LGND) share price targets
Complete technical analysis of Ligand Pharmaceuticals (LGND) by charts plus indicators, forecast predictions and share price targets for Ligand Pharmaceuticals (LGND)
Ligand Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Ligand Pharmaceuticals is 164140
| Date | Daily Closing Price | Open | High | Low | Volume |
| 25 Thu Apr 2024 | 70.37 | 70.24 | 71.17 | 69.63 | 0.65 times |
| 24 Wed Apr 2024 | 71.00 | 69.46 | 71.00 | 69.17 | 0.932 times |
| 23 Tue Apr 2024 | 69.89 | 68.50 | 71.16 | 68.50 | 0.857 times |
| 22 Mon Apr 2024 | 68.53 | 72.98 | 72.98 | 67.72 | 1.507 times |
| 19 Fri Apr 2024 | 72.47 | 71.93 | 72.95 | 71.16 | 0.835 times |
| 18 Thu Apr 2024 | 72.52 | 78.70 | 78.70 | 72.50 | 0.799 times |
| 17 Wed Apr 2024 | 78.87 | 79.92 | 80.53 | 78.30 | 1.095 times |
| 16 Tue Apr 2024 | 79.92 | 79.47 | 81.52 | 79.06 | 0.965 times |
| 15 Mon Apr 2024 | 79.77 | 80.81 | 80.96 | 79.09 | 1.07 times |
| 12 Fri Apr 2024 | 81.36 | 81.48 | 81.73 | 80.43 | 1.044 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 71.6, but if it comes above 71.6, then a intra day buy could be more profitable.
If you take a sell trade below 71.6, then use 71.6 as stoploss and 66.5 as target. However if you take a buy trade in stock , then use 71.6 as stoploss and 75.93 as target.
Share price targets for Ligand Pharmaceuticals (LGND)
| Target Type | Value |
| Downside Target | 57.14 |
| Downside Target | 67.53 |
| Upside Target | 70.58 |
| Upside Target | 72.98 |
| Upside Target | 76.66 |
| Upside Target | 77.48 |
| Upside Target | 78.87 |
| Upside Target | 80.94 |
| Upside Target | 81.52 |
| Upside Target | 81.73 |
| Upside Target | 94.57 |
Intraday share price targets for Ligand Pharmaceuticals (LGND)
| Target Type | Value |
| Downside Intraday Target | 67.73 |
| Downside Intraday Target | 65.1 |
| Upside Intraday Target | 72.99 |
| Upside Intraday Target | 75.62 |
| Downside Intraday Target | 70.36 |
Weekly technical analysis of Ligand Pharmaceuticals (LGND)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 25 Thu Apr 2024 | 70.37 | 72.98 | 72.98 | 67.72 | 0.828 times |
| 19 Fri Apr 2024 | 72.47 | 80.81 | 81.52 | 71.16 | 1.019 times |
| 12 Fri Apr 2024 | 81.36 | 77.49 | 81.73 | 77.48 | 0.869 times |
| 05 Fri Apr 2024 | 77.96 | 73.35 | 78.87 | 71.22 | 1.71 times |
| 28 Thu Mar 2024 | 73.10 | 71.38 | 73.42 | 68.25 | 0.882 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ligand Pharmaceuticals (LGND)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 25 Thu Apr 2024 | 70.37 | 73.35 | 81.73 | 67.72 | 0.77 times |
| 28 Thu Mar 2024 | 73.10 | 80.05 | 80.94 | 68.25 | 1.141 times |
| 29 Thu Feb 2024 | 79.35 | 73.61 | 94.57 | 70.58 | 1.604 times |
| 31 Wed Jan 2024 | 73.10 | 71.49 | 76.66 | 67.53 | 0.762 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ligand Pharmaceuticals (LGND)
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term and the sell signal is strong.
Ligand Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 74.57 and Ligand Pharmaceuticals (LGND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Ligand Pharmaceuticals ( (LGND) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Ligand Pharmaceuticals stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Ligand Pharmaceuticals in short term and the sell signal is strong.
Ligand Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Ligand Pharmaceuticals in short term
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Ligand Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 74.57 and Ligand Pharmaceuticals (LGND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Ligand Pharmaceuticals (LGND) stock. Volume based technical analysis of Ligand Pharmaceuticals (LGND) stock is negative.
Ligand Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.